Cargando…

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL

SIMPLE SUMMARY: The Epstein–Barr virus (EBV) contributes to different forms of human cancer, including a subset of classical Hodgkin lymphoma (cHL), a B-cell lymphoma with unusual histological features. Although the pathogenesis of EBV-associated cHL remains to be elucidated, biological investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nohtani, Mahdi, Vrzalikova, Katerina, Ibrahim, Maha, Powell, Judith E., Fennell, Éanna, Morgan, Susan, Grundy, Richard, McCarthy, Keith, Dewberry, Sarah, Bouchal, Jan, Bouchalova, Katerina, Kearns, Pamela, Murray, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454639/ https://www.ncbi.nlm.nih.gov/pubmed/36077832 http://dx.doi.org/10.3390/cancers14174297

Ejemplares similares

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
por: Chen, Robert, et al.
Publicado: (2015)

The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
por: Rajabto, Wulyo, et al.
Publicado: (2022)

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
por: Laura, Korin, et al.
Publicado: (2022)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
por: Selby, P., et al.
Publicado: (1990)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma
por: Cocorocchio, E, et al.
Publicado: (2010)

A Note on the Geometry of CHL Heterotic Strings
por: Lerche, Wolfgang, et al.
Publicado: (1997)

Evolution of light-harvesting complex proteins from Chl c-containing algae
por: Hoffman, Gabriel E, et al.
Publicado: (2011)

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982)

Structural characterisation of the Chaetomium thermophilum Chl1 helicase
por: Hodáková, Zuzana, et al.
Publicado: (2021)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers
por: Viviani, Simonetta, et al.
Publicado: (2022)

Four-derivative couplings and BPS dyons in heterotic CHL orbifolds
por: Bossard, Guillaume, et al.
Publicado: (2017)

CHL1 gene polymorphisms increase lung cancer susceptibility
por: Tian, Wen, et al.
Publicado: (2018)

Concurrent malignant melanoma and cutaneous involvement by classical hodgkin lymphoma (CHL) in a 63 year-old man
por: Gru, Alejandro A, et al.
Publicado: (2013)

1588. Epidemiology of Chronic High Level (CHL) Epstein-Barr virus (EBV) DNAemia in Pediatric Solid Organ Transplant Recipients (SOTR) at Texas Children’s Hospital (TCH)
por: Valencia Deray, Kristen G, et al.
Publicado: (2022)

CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells
por: Yang, Zhai, et al.
Publicado: (2017)

CHL1 gene acts as a tumor suppressor in human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2018)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
por: Viviani, Simonetta, et al.
Publicado: (2022)

P103: Comparison of PET-derived parameters in program cell death-1 inhibitor and CD30 antibody drug conjugate-based therapies in patients with advanced stage cHL: A single center experience.
por: Kamel, Serageldin, et al.
Publicado: (2022)

Co-expression of a SARP Family Activator ChlF2 and a Type II Thioesterase ChlK Led to High Production of Chlorothricin in Streptomyces antibioticus DSM 40725
por: Li, Yue, et al.
Publicado: (2020)

CHL1 Is a Selective Organizer of the Presynaptic Machinery Chaperoning the SNARE Complex
por: Andreyeva, Aksana, et al.
Publicado: (2010)

Differential Expression of CHL1 Gene during Development of Major Human Cancers
por: Senchenko, Vera N., et al.
Publicado: (2011)

The ChlD subunit links the motor and porphyrin binding subunits of magnesium chelatase
por: Farmer, David A., et al.
Publicado: (2019)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Variations in the Distribution of Chl-a and Simulation Using a Multiple Regression Model
por: Deng, Jiancai, et al.
Publicado: (2019)

CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
por: Wachowiak, Robin, et al.
Publicado: (2019)

chlB Requirement for Chlorophyll Biosynthesis under Short Photoperiod in Marchantia polymorpha L.
por: Ueda, Minoru, et al.
Publicado: (2014)

De novo microduplication of CHL1 in a patient with non-syndromic developmental phenotypes
por: Palumbo, Orazio, et al.
Publicado: (2015)

Oscillation Kinetics of Post-illumination Increase in Chl Fluorescence in Cyanobacterium Synechocystis PCC 6803
por: Xu, Min, et al.
Publicado: (2016)

The Q Motif Is Involved in DNA Binding but Not ATP Binding in ChlR1 Helicase
por: Ding, Hao, et al.
Publicado: (2015)

MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action
por: Oved, Keren, et al.
Publicado: (2017)

Hsp90 Is Essential for Chl1-Mediated Chromosome Segregation and Sister Chromatid Cohesion
por: Khurana, Nidhi, et al.
Publicado: (2018)

Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

CHL1 deletion is associated with cognitive and language disabilities – Case report and review of literature
por: Tsuboyama, Melissa, et al.
Publicado: (2021)

Chl1 helicase controls replication fork progression by regulating dNTP pools
por: Batté, Amandine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i283gtdm802nci2o5hc7qmad7o